CHINA> National
|
Mainland reports 3 new H1N1 flu deaths
(Xinhua)
Updated: 2009-11-06 00:23 BEIJING: The Chinese mainland reported three more deaths from A(H1N1) flu Thursday after at least eight people had fallen victim to the disease, authorities said.
A boy from Qingtongxia City in northwest China's Ningxia Hui Autonomous Region died late Wednesday in regional capital Yinchuan. Test result confirmed Thursday he was infected with A(H1N1). He was the first death from A(H1N1) in the region, an official with the regional health bureau said. As of 3 p.m. Thursday, the region had reported 398 cases of A(H1N1) flu, 179 of which had recovered, the official said.
A 14-year-old school student surnamed Guo, from Fuyun County in Xinjiang's Altay Prefecture, was treated at local clinics for fever on October 30. He was transferred to the Fuyun People's Hospital Tuesday, but later died, said the regional health department. Tests on Wednesday showed Guo died of A(H1N1)flu, viral pneumonia and acute respiratory distress syndrome, the department said. In Hebei Province a senior high school student died on October 29, local official said. As of Wednesday, the province had reported 1,042 A(H1N1)flu cases, of which 736 had been cured and left hospital, the official said. Eight deaths from A(H1N1) had earlier been reported from Beijing, Tibet, Qinghai, Xinjiang, Heilongjiang, Guangxi, Hunan and Zhejiang. A 32-year-old Russian man died of the virus in Beijing Monday. He arrived from Russia on October 28 by air and went to hospital on Sunday with severe breathing difficulties and other symptoms. China's Ministry of Health on Thursday stressed that local medical institutions and schools should not charge students for A(H1N1) flu vaccine inoculations. To effectively combat the influenza, the Chinese government has announced to provide students, medical staff, public servants and elderly people with A(H1N1) flu vaccine free of charge. As the first country that issued a production license for A(H1N1) vaccines, China had inoculated more than 3.78 million people as of October 31, with no reports of serious adverse reaction, according to the Health Ministry. |